New injection could help shed pounds in obesity trial

NCT ID NCT07114419

Recruiting now Disease control Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated May 17, 2026 · Updated 28 times

Summary

This study tests a new medication called efsubaglutide alfa to help people with overweight or obesity lose weight. About 200 adults will receive either the drug or a placebo for 22 weeks. The main goal is to see how much weight they lose and if the treatment is safe.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Canopy Clinical Altona North
RECRUITING

North Altona, Australia

Contact
Canopy Clinical Northern Beaches
RECRUITING

Brookvale, Australia

Contact
Canopy Clinical Sutherland Shire
RECRUITING

Miranda, Australia

Contact
Canopy Clinical Wollongong
RECRUITING

Wollongong, Australia

Contact
Fusion Clinical Research
RECRUITING

Norwood, Australia

Contact

Conditions

Explore the condition pages connected to this study.

OBESITY AND OVERWEIGHT